The authors conclude that C-peptide treatment at a replacement dose for 6 months improves early neuropathic symptoms of type 1 diabetes, and they stress the importance of early intervention.
Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback